BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 16935834)

  • 1. Naproxen release from sustained release matrix system and effect of cellulose derivatives.
    Sarfraz MK; Rehman NU; Mohsin S
    Pak J Pharm Sci; 2006 Jul; 19(3):251-5. PubMed ID: 16935834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethyl cellulose-based solid matrix system for sustaining release of naproxen.
    Sarfraz MK; Nisar-Ur-Rehman ; Ahmed S; Ashraf M; Mohsin S
    Pak J Biol Sci; 2007 Feb; 10(4):668-72. PubMed ID: 19069556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo studies on HPMC-K-100 M matrices containing naproxen sodium.
    Kumar SM; Chandrasekar MJ; Gopinath R; Srinivasan R; Nanjan MJ; Suresh B
    Drug Deliv; 2007 Mar; 14(3):163-9. PubMed ID: 17454036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets.
    Quinten T; De Beer T; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2009 Jan; 71(1):145-54. PubMed ID: 18511248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasticizer effect and comparative evaluation of cellulose acetate and ethylcellulose-HPMC combination coatings as semipermeable membranes for oral osmotic pumps of naproxen sodium.
    Ramakrishna N; Mishra B
    Drug Dev Ind Pharm; 2002 Apr; 28(4):403-12. PubMed ID: 12056533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and in vitro evaluation of controlled release hydrophilic matrix tablets of ketorolac tromethamine using factorial design.
    Genç L; Jalvand E
    Drug Dev Ind Pharm; 2008 Aug; 34(8):903-10. PubMed ID: 18686094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled-release naproxen using micronized ethyl cellulose by wet-granulation and solid-dispersion method.
    Iqbal Z; Babar A; Ashraf M
    Drug Dev Ind Pharm; 2002; 28(2):129-34. PubMed ID: 11926356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hydroxypropyl methylcellulose and hydrogenated castor oil on naproxen release from sustained-release tablets.
    Amaral MH; Lobo JM; Ferreira DC
    AAPS PharmSciTech; 2001 Apr; 2(2):E6. PubMed ID: 14727881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of cellulose ether mixtures on ibuprofen release: MC25, HPC and HPMC K100M.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Pharm Dev Technol; 2006; 11(2):213-28. PubMed ID: 16749532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and evaluation of controlled release matrices of ketoprofen and influence of different co-excipients on the release mechanism.
    Wahab A; Khan GM; Akhlaq M; Khan NR; Hussain A; Khan MF; Khan H
    Pharmazie; 2011 Sep; 66(9):677-83. PubMed ID: 22026123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel approach to sustained pseudoephedrine release: differentially coated mini-tablets in HPMC capsules.
    Ishida M; Abe K; Hashizume M; Kawamura M
    Int J Pharm; 2008 Jul; 359(1-2):46-52. PubMed ID: 18467046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of liquisolid formulations on dissolution of naproxen.
    Tiong N; Elkordy AA
    Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cellulose ether polymers on ibuprofen release from matrix tablets.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2005 Aug; 31(7):653-65. PubMed ID: 16207613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the in vitro drug release kinetics from controlled release diclofenac potassium-ethocel matrix tablets and the influence of co-excipients on drug release patterns.
    Shah SU; Shah KU; Rehman A; Khan GM
    Pak J Pharm Sci; 2011 Apr; 24(2):183-92. PubMed ID: 21454168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Directly compressed mini matrix tablets containing ibuprofen: preparation and evaluation of sustained release.
    Lopes CM; Sousa Lobo JM; Costa P; Pinto JF
    Drug Dev Ind Pharm; 2006 Jan; 32(1):95-106. PubMed ID: 16455608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.
    Huang Y; Khanvilkar KH; Moore AD; Hilliard-Lott M
    Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and tablet hardness on drug release using a 2(3) full factorial design.
    Khanvilkar KH; Huang Y; Moore AD
    Drug Dev Ind Pharm; 2002 May; 28(5):601-8. PubMed ID: 12098849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate.
    Pradhan R; Kim YI; Chang SW; Kim JO
    Int J Pharm; 2014 Jan; 460(1-2):205-11. PubMed ID: 24184032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.